Masimo Corp. (MASI) EVP Yongsam Lee Sells 30,000 Shares
Masimo Corp. (NASDAQ:MASI) EVP Yongsam Lee sold 30,000 shares of the stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $60.50, for a total transaction of $1,815,000.00. Following the sale, the executive vice president now owns 93,000 shares of the company’s stock, valued at approximately $5,626,500. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Masimo Corp. (NASDAQ:MASI) opened at 58.92 on Thursday. Masimo Corp. has a one year low of $33.03 and a one year high of $60.81. The firm has a 50-day moving average of $59.19 and a 200-day moving average of $51.89. The stock has a market capitalization of $2.91 billion, a PE ratio of 30.90 and a beta of 0.70.
Masimo Corp. (NASDAQ:MASI) last posted its earnings results on Wednesday, August 3rd. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.16. The firm earned $172.64 million during the quarter, compared to analyst estimates of $166.02 million. Masimo Corp. had a net margin of 15.40% and a return on equity of 29.07%. Masimo Corp.’s revenue was up 10.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.36 EPS. On average, equities research analysts forecast that Masimo Corp. will post $2.02 earnings per share for the current year.
A number of equities research analysts recently commented on MASI shares. Piper Jaffray Cos. restated an “overweight” rating and issued a $55.00 price objective (up previously from $52.00) on shares of Masimo Corp. in a research report on Friday, August 5th. Wedbush restated an “outperform” rating and issued a $63.00 price objective (up previously from $60.00) on shares of Masimo Corp. in a research report on Thursday, August 4th. BTIG Research restated a “hold” rating on shares of Masimo Corp. in a research report on Friday, August 5th. Finally, Zacks Investment Research downgraded shares of Masimo Corp. from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 4th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Masimo Corp. currently has an average rating of “Buy” and an average target price of $52.60.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Victory Capital Management Inc. raised its position in Masimo Corp. by 76.9% in the second quarter. Victory Capital Management Inc. now owns 2,148 shares of the company’s stock worth $113,000 after buying an additional 934 shares during the last quarter. Tower Research Capital LLC TRC purchased a new position in Masimo Corp. during the second quarter worth about $116,000. Quantbot Technologies LP purchased a new position in Masimo Corp. during the second quarter worth about $155,000. Reynders McVeigh Capital Management LLC purchased a new position in Masimo Corp. during the second quarter worth about $203,000. Finally, Janney Capital Management LLC purchased a new position in Masimo Corp. during the second quarter worth about $205,000. 79.88% of the stock is owned by hedge funds and other institutional investors.
About Masimo Corp.
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.